Cargando…

Kawasaki disease following immunization reported to the Canadian Immunization Monitoring Program ACTive (IMPACT) from 2013 to 2018

Kawasaki disease (KD) is an acute systemic vasculitis primarily affecting children younger than 5 y of age that has been reported as an adverse event following immunization (AEFI). The Canadian Immunization Monitoring Program ACTive (IMPACT) conducts active surveillance for KD following immunization...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alsager, Khaled, Khatri Vadlamudi, Nirma, Jadavji, Taj, Bettinger, Julie A., Constantinescu, Cora, Vaudry, Wendry, Tan, Ben, Sauvé, Laura, Sadarangani, Manish, Halperin, Scott A., Top, Karina A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Vaccine Safety – Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621042/ https://www.ncbi.nlm.nih.gov/pubmed/35797728 http://dx.doi.org/10.1080/21645515.2022.2088215

Ejemplares similares

Clinical Presentations and Outcomes of Children in Canada With Recurrent Invasive Pneumococcal Disease From the IMPACT Surveillance Network
por: Murad, Yousif, et al.
Publicado: (2022)

2613. Pediatric respiratory syncytial virus hospitalizations, 2017 to 2022, the Canadian Immunization Monitoring Program Active (IMPACT)
por: Bourdeau, Malou, et al.
Publicado: (2023)

Clinical trials show similar safety outcomes including febrile convulsion rates for GSK’s and Merck’s measles-mumps-rubella (MMR) vaccines
por: Habib, Md Ahsan, et al.
Publicado: (2023)

Assessment of adherence to pre-vaccination precautions and AEFI reporting practices during BCG vaccination in 4 hospitals in Ghana
por: Yamoah, Peter, et al.
Publicado: (2023)

Safety of BCG vaccination and revaccination in healthcare workers
por: Villanueva, Paola, et al.
Publicado: (2023)

Oral adverse events following COVID-19 and influenza vaccination in Australia
por: Riad, Abanoub, et al.
Publicado: (2023)

Strategies to Prevent Early and Late-Onset Group B Streptococcal Infection via Interventions in Pregnancy
por: Delara, Mahin, et al.
Publicado: (2023)

Pediatric RSV-Associated Hospitalizations Before and During the COVID-19 Pandemic
por: Bourdeau, Malou, et al.
Publicado: (2023)

Barriers to healthcare workers reporting adverse events following immunization in Zhejiang province, China
por: Lv, Huakun, et al.
Publicado: (2022)

Incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate pneumococcal vaccine in British Columbia: A retrospective cohort study
por: Vadlamudi, Nirma Khatri, et al.
Publicado: (2020)

Optimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular Parasites
por: Hofmeyer, Kimberly A., et al.
Publicado: (2016)

Bioactive Immune Components of Anti-Diarrheagenic Enterotoxigenic Escherichia coli Hyperimmune Bovine Colostrum Products
por: Sears, Khandra T., et al.
Publicado: (2017)

The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice
por: Wegmann, Frank, et al.
Publicado: (2015)

Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999–2015
por: Abu-Raya, Bahaa, et al.
Publicado: (2018)

Physician vaccination practices in mild to moderate inborn errors of immunity and retrospective review of vaccine completeness in IEI: results from the Canadian Immunization Research Network
por: Suresh, Sneha, et al.
Publicado: (2022)

Dose Selection for an Adjuvanted Respiratory Syncytial Virus F Protein Vaccine for Older Adults Based on Humoral and Cellular Immune Responses
por: Falloon, Judith, et al.
Publicado: (2017)

1188. The Effect Of The COVID-19 Pandemic On Influenza-Related Hospitalization, Intensive Care Admission And Mortality In Canadian Children
por: Groves, Helen E, et al.
Publicado: (2021)

Routine Immunization Coverage and Immunization Card Retention in Pakistan: Results From a Cross-sectional National Survey
por: Hussain, Imtiaz, et al.
Publicado: (2023)

Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap
por: Gray, Glenda E., et al.
Publicado: (2016)

2596. Title: The Dynamics Of Invasive Pneumococcal Disease (IPD) due to Streptococcus pneumoniae and Impact Of Pneumococcal Conjugate Vaccines (PCVs) In Canada From 2000-2019
por: Ramos, Bernice N, et al.
Publicado: (2023)

Waning Vaccine Immunity and Vaccination Responses in Children Treated for Acute Lymphoblastic Leukemia: A Canadian Immunization Research Network Study
por: Top, Karina A, et al.
Publicado: (2020)

Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services( )
por: Top, Karina A, et al.
Publicado: (2022)

Improving Tdap maternal immunization rate in Saudi Arabia
por: Aldoosari, Agariad, et al.
Publicado: (2023)

B Cells from Aged Mice Do Not Have Intrinsic Defects in Affinity Maturation in Response to Immunization
por: Lee, Jia Le, et al.
Publicado: (2023)

Efficacy and Safety of the Pneumococcal Conjugate-13 Valent Vaccine in Adults
por: Marra, Fawziah, et al.
Publicado: (2019)

Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review
por: Lau, Oscar, et al.
Publicado: (2022)

Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques
por: White, A. D., et al.
Publicado: (2015)

Will vaccine-derived protective immunity curtail COVID-19 variants in the US?
por: Mancuso, Marina, et al.
Publicado: (2021)

Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial
por: Dunning, Andrew J., et al.
Publicado: (2016)

Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A
por: Harris, Stephanie A., et al.
Publicado: (2014)

IgG1 Is Required for Optimal Protection after Immunization with the Purified Porin OmpD from Salmonella Typhimurium
por: Zhang, Yang, et al.
Publicado: (2017)

The politics of vaccine hesitancy in Europe
por: Stoeckel, Florian, et al.
Publicado: (2022)

Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis
por: Schenfeld, Jennifer, et al.
Publicado: (2017)

Les vaccins dans la prévention des infections associées aux soins
por: Gagneux-Brunon, A., et al.
Publicado: (2017)

Switched forced SEIRDV compartmental models to monitor COVID-19 spread and immunization in Italy
por: Antonelli, Erminia, et al.
Publicado: (2021)

The Impact of Transitioning to Prospective Contouring and Planning Rounds as Peer Review
por: Surucu, Murat, et al.
Publicado: (2019)

GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis
por: King, Thomas H., et al.
Publicado: (2017)

Stronger together: Analytical techniques for recombinant adeno associated virus
por: Hutanu, Andrei, et al.
Publicado: (2021)

Implications of Differential Age Distribution of Disease-Associated Meningococcal Lineages for Vaccine Development
por: Brehony, Carina, et al.
Publicado: (2014)

Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis
por: Rossi, Omar, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sv2tcfrqthbb4ju61os11aps6m